Trial · NCT05288062
Adverse events60
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 60
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Cohort B (Lenalidomide, Dexamethasone) | 2 | 5 | 2 |
| other | Anemia | Blood and lymphatic system disorders | Cohort C (Lenalidomide, Dexamethasone, Pomalidomide) | 2 | 11 | 2 |
| other | Sinus tachycardia | Cardiac disorders | Cohort B (Lenalidomide, Dexamethasone) | 1 | 5 | 1 |
| other | Sinus tachycardia | Cardiac disorders | Cohort C (Lenalidomide, Dexamethasone, Pomalidomide) | 0 | 11 | 0 |
| other | Eye pain | Eye disorders | Cohort B (Lenalidomide, Dexamethasone) | 1 | 5 | 1 |
| other | Eye pain | Eye disorders | Cohort C (Lenalidomide, Dexamethasone, Pomalidomide) | 0 | 11 | 0 |
| other | Abdominal pain | Gastrointestinal disorders | Cohort B (Lenalidomide, Dexamethasone) | 0 | 5 | 0 |
| other | Abdominal pain | Gastrointestinal disorders | Cohort C (Lenalidomide, Dexamethasone, Pomalidomide) | 1 | 11 | 1 |
| other | Constipation | Gastrointestinal disorders | Cohort B (Lenalidomide, Dexamethasone) | 2 | 5 | 2 |
| other | Constipation | Gastrointestinal disorders | Cohort C (Lenalidomide, Dexamethasone, Pomalidomide) | 1 | 11 | 1 |
| other | Diarrhea | Gastrointestinal disorders | Cohort B (Lenalidomide, Dexamethasone) | 0 | 5 | 0 |
| other | Diarrhea | Gastrointestinal disorders | Cohort C (Lenalidomide, Dexamethasone, Pomalidomide) | 2 | 11 | 3 |
| other | Nausea | Gastrointestinal disorders | Cohort B (Lenalidomide, Dexamethasone) | 1 | 5 | 1 |
| other | Nausea | Gastrointestinal disorders | Cohort C (Lenalidomide, Dexamethasone, Pomalidomide) | 0 | 11 | 0 |
| other | Fatigue | General disorders | Cohort B (Lenalidomide, Dexamethasone) | 3 | 5 | 3 |
| other | Fatigue | General disorders | Cohort C (Lenalidomide, Dexamethasone, Pomalidomide) | 4 | 11 | 4 |
| other | Gait disturbance | General disorders | Cohort B (Lenalidomide, Dexamethasone) | 0 | 5 | 0 |
| other | Gait disturbance | General disorders | Cohort C (Lenalidomide, Dexamethasone, Pomalidomide) | 1 | 11 | 1 |
| other | Allergic reaction | Immune system disorders | Cohort B (Lenalidomide, Dexamethasone) | 1 | 5 | 1 |
| other | Allergic reaction | Immune system disorders | Cohort C (Lenalidomide, Dexamethasone, Pomalidomide) | 1 | 11 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05288062/events